ETR:GXI - Gerresheimer Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Gerresheimer AG Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add €68.80 -2.90 (-4.04 %) (As of 02/24/2020 06:22 AM ET) Add Compare Today's Range€68.55Now: €68.80▼€70.9050-Day Range€64.00MA: €69.41▼€74.0052-Week Range€61.95Now: €68.80▼€74.80Volume23,706 shsAverage Volume140,925 shsMarket Capitalization$2.16 billionP/E Ratio10.43Dividend Yield1.61%BetaN/A ProfileAnalyst RatingsAdvanced ChartHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices. Read More… Industry, Sector and Symbol Stock Exchange ETR Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolETR:GXI Previous Symbol CUSIPN/A CIKN/A Webhttp://www.gerresheimer.com/ Phone+49-211-618100Debt Debt-to-Equity Ratio65.99 Current Ratio0.81 Quick Ratio0.54Price-To-Earnings Trailing P/E Ratio10.43 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$1.41 billion Price / Sales1.53 Cash Flow€2.98 per share Price / Cash Flow23.06 Book Value€32.27 per share Price / Book2.13Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees9,867 Outstanding Shares31,400,000Market Cap$2.16 billion Next Earnings DateN/A OptionableNot Optionable Receive GXI News and Ratings via Email Sign-up to receive the latest news and ratings for GXI and its competitors with MarketBeat's FREE daily newsletter. GXI Rates by TradingView Gerresheimer (ETR:GXI) Frequently Asked Questions What is Gerresheimer's stock symbol? Gerresheimer trades on the ETR under the ticker symbol "GXI." What price target have analysts set for GXI? 10 brokerages have issued 12-month price targets for Gerresheimer's shares. Their forecasts range from €50.00 to €85.00. On average, they anticipate Gerresheimer's stock price to reach €73.29 in the next year. This suggests a possible upside of 6.5% from the stock's current price. View Analyst Price Targets for Gerresheimer. What is the consensus analysts' recommendation for Gerresheimer? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Gerresheimer in the last year. There are currently 2 sell ratings, 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Gerresheimer. Has Gerresheimer been receiving favorable news coverage? Press coverage about GXI stock has been trending very negative on Monday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Gerresheimer earned a coverage optimism score of -3.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Gerresheimer. Who are some of Gerresheimer's key competitors? Some companies that are related to Gerresheimer include Envista (NVST), Ansell (ANN), Nanosonics (NAN), Enerplus (ERF), Advanced Medical Solutions Group (AMS), Clover (CLV), CRH Medical (CRH), CRH Medical (CRHM), CRH Medical (CRHM), InfuSystem (INFU), Bovie Medical (BVX), Tristel (TSTL), Milestone Scientific (MLSS), SDI (SDI) and IsoRay (ISR). What other stocks do shareholders of Gerresheimer own? Based on aggregate information from My MarketBeat watchlists, some companies that other Gerresheimer investors own include Acer Therapeutics (ACER), Consort Medical (CSRT), Arix Bioscience (ARIX), Allergy Therapeutics (AGY), Henkel AG & Co KGaA (HEN3), Sartorius (SRT), Siemens Healthineers (SHL), STADA Arzneimit/AKT o.N. (SAZ), Evotec (EVT) and Neptune Technologies & Bioressources (NTB). Who are Gerresheimer's key executives? Gerresheimer's management team includes the folowing people: Mr. Dietmar Siemssen, CEO & Member of Management Board (Age 56)Dr. Lukas Burkhardt, Member of Management Board (Age 40)Ms. Katja Schnitzler, Group Director of Bus. Excellence & Continuous Improvement and Member of the Supervisory Board (Age 38)Ms. Severine Camp, Corp. Sr. Director of Investor RelationsMr. Jens Kürten, Group Sr. Director of Communication & Marketing and Press Officer of Corp. Media What is Gerresheimer's stock price today? One share of GXI stock can currently be purchased for approximately €68.80. How big of a company is Gerresheimer? Gerresheimer has a market capitalization of $2.16 billion and generates $1.41 billion in revenue each year. Gerresheimer employs 9,867 workers across the globe.View Additional Information About Gerresheimer. What is Gerresheimer's official website? The official website for Gerresheimer is http://www.gerresheimer.com/. How can I contact Gerresheimer? Gerresheimer's mailing address is Klaus-Bungert-Strasse 4, DUESSELDORF, 40468, Germany. The company can be reached via phone at +49-211-618100. MarketBeat Community Rating for Gerresheimer (ETR GXI)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 208 (Vote Outperform)Underperform Votes: 228 (Vote Underperform)Total Votes: 436MarketBeat's community ratings are surveys of what our community members think about Gerresheimer and other stocks. Vote "Outperform" if you believe GXI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GXI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/24/2020 by MarketBeat.com StaffFeatured Article: Balance Sheet
